Lessons from randomised direct comparative trials-Reference-Cited by-同舟云学术

Lessons from randomised direct comparative trials

Published:2009-02 Issue: Volume:277 Page:S19-S24
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Achiron Anat,Fredrikson Sten

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference23 articles.

1. Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review;Galetta;Arch Intern Med,2002

2. Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial;Panitch;Neurology,2002

3. Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN);Durelli;Lancet,2002

4. Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial;Mikol;Lancet Neurol,2008

5. Betaseron vs. Copaxone in MS with triple-dose gadolinium and 3-T MRI Endpoints (BECOME): announcement of final primary study outcome;Wolansky;Mult Scler,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations;Pharmacoepidemiology and Drug Safety;2017-04-03

2. Interferon-β1b in der Multiple-Sklerose-Therapie;Der Nervenarzt;2013-05-15

3. Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America;Therapeutic Advances in Neurological Disorders;2011-10-17

4. Possible clinical outcome measures for clinical trials in patients with multiple sclerosis;Therapeutic Advances in Neurological Disorders;2010-06-23

5. Oral Therapy for Multiple Sclerosis — Sea Change or Incremental Step?;New England Journal of Medicine;2010-02-04